New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
08:02 EDTRMDResMed receives permanent injuction against APEX in Germany
ResMed announced it has won a permanent injunction in Germany against Taiwanese medical device manufacturer APEX Medical Corp., prohibiting sales of infringing headgear used on APEX WiZARD 210 and 220 masks. The judgment was entered by the Regional District Court in Munich, is appealable, and applies throughout Germany. The permanent injunction continues a preliminary injunction that was entered by the same court on Nov. 12, 2013. The court rejected APEX's request to stay the injunction and its challenge to the validity of ResMed's patent. The judgment also requires APEX to forfeit its inventory of infringing products, to report on its sales of the infringing products, and to pay damages to ResMed. ResMed has also filed separate patent infringement lawsuits in the same court seeking damages and permanent injunctions to stop infringement of other ResMed patents. The trials of those cases will occur in the fall of 2014.
News For RMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2015
10:12 EDTRMDResMed downgraded to Sell after Q4 results at Deutsche Bank
Subscribe for More Information
10:03 EDTRMDResMed downgraded to Sell from Hold at Deutsche Bank (pre-open)
10:02 EDTRMDOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: ACE Limited (ACE) upgraded to Outperform at Bernstein on Chubb deal potential... Aixtron (AIXG) upgraded to Outperform from Neutral at Exane BNP Paribas... Anglo American (AAUKY) upgraded to Neutral from Underperform at Exane BNP Paribas... Antero Resources (AR) upgraded to Buy from Accumulate at KLR Group... Autoliv (ALV) upgraded to Outperform from Neutral at Credit Suisse... Barrick Gold (ABX) upgraded to Hold from Sell at Canaccord... California Water Service (CWT) upgraded to Buy from Neutral at Hilliard Lyons... Calpine (CPN) upgraded to Buy from Hold at Evercore ISI... CenturyLink (CTL) upgraded to Hold from Underperform at Jefferies... China Unicom (CHU) upgraded to Hold from Reduce at HSBC... Chubb (CB) upgraded to Outperform from Market Perform at Bernstein... Delphi (DLPH) upgraded to Buy from Outperform at CLSA... Diebold (DBD) upgraded to Outperform from Neutral at Wedbush... Discovery (DISCA) upgraded to Neutral from Sell at UBS... Eldorado Gold (EGO) upgraded to Buy at Canaccord... GoPro (GPRO) upgraded to Buy with $90 price target at Citi... Guidance Software (GUID) upgraded to Buy from Hold at Gabelli... H&E Equipment (HEES) upgraded to Buy from Neutral at UBS... Integra LifeSciences (IART) upgraded to Overweight from Neutral at JPMorgan... Lenovo (LNVGY) upgraded to Hold from Underperform at Jefferies... Methanex (MEOH) upgraded to Buy from Hold at TD Securities... Molina Healthcare (MOH) upgraded on strong results at Stifel... NCI, Inc. (NCIT) upgraded to Outperform from Market Perform at Cowen... Nationstar (NSM) upgraded to Market Perform from Underperform at FBR Capital... NetScout (NTCT) upgraded at Sterne Agee CRT... Pacira (PCRX) upgraded to Neutral from Underperform at BofA/Merrill... Premiere Global (PGI) upgraded to Strong Buy from Outperform at Raymond James... Regal Entertainment (RGC) upgraded to Outperform from Neutral at Wedbush... ResMed (RMD) upgraded to Overweight from Equal Weight at Morgan Stanley... RingCentral (RNG) upgraded to Strong Buy from Outperform at Raymond James... Robert Half (RHI) upgraded to Buy from Hold at Jefferies... SkyWest (SKYW) upgraded to Buy from Hold at Evercore ISI... Stratasys (SSYS) upgraded to Overweight from Neutral at Piper Jaffray... Under Armour (UA) upgraded to Buy from Hold at Argus... Western Union (WU) upgraded to Equal Weight from Underweight at Barclays... Yahoo Japan (YAHOY) upgraded to Buy from Hold at Jefferies... eHealth (EHTH) upgraded to Neutral from Underperform at BofA/Merrill.
09:53 EDTRMDResMed upgraded to Overweight from Equal Weight at Morgan Stanley
Subscribe for More Information
July 30, 2015
16:21 EDTRMDResMed reports Q4 non-GAAP EPS 68c, consensus 65c
Reports Q4 revenue $453.1M, consensus $436.73M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use